GRK5 and cardiac hypertrophy: GRK5-Leu41 accelerated isoproterenol-promoted β ARs desensitization, suggesting that, like β-blockers, it might protect hearts from the effects of persistent β AR stimulation, that is, cardiac dilation, ventricular hypertrophy and heart failure [25].